PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE

Yazar
Klatte, Tobias
Erdem, Selçuk
Rubio-Briones, Jose
Heck, Matthias
Porpiglia, Francesco
Checcucci, Enrico
Van Bruwaene, Siska
Linares, Estefania
Hevia, Vital
Musquera, Mireia
Musquera, Mireia
D'anna, Mauricio
Derweesh, Ithaar
Meagher, Margaret F.
Ghali, Fadi
Autorino, Riccardo
Vecchia, Alessandro
Guruli, Georgi
Pavan, Nicola
Claps, Francesco
Antonelli, Alessandro
Palumbo, Carlotta
Antonelli, Alessandro
Carmen Mir, M.
Marchioni, Michele
Campi, Riccardo
Minervini, Andrea
Roussel, Eduard
Albertsen, Maarteen
Capitanio, Umberto
Maximilian, Kriegmair
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/5386
Koleksiyonlar